| abstract |
An agent for improving at least one of hyperglycemia, hyperinsulinism, insulin resistance, glucose intolerance, diabetes, hypercholesterolemia, atherosclerosis, obesity, and cardiovascular disease and use thereof To provide. The agents for the treatment of certain lipid and glucose metabolic diseases and combinations thereof of the present invention comprise a first amount of D 1 dopamine agonist and a second amount of ergot alkaloid dopamine D 2 agonist. . [Selection figure] None |